SCHEMBL19145745

SCHEMBL19145745

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](NCc2ccccc2)[C@H]1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 6/20 0.66
▸ SLC29A1 Q99808 3/20 0.66
▸ DOT1L Q8TEK3 2/20 0.66
▸ ADORA2A P29274 2/20 0.66
▸ ADORA1 P30542 2/20 0.66
▸ DPP4 P27487 1/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ SLC28A1 O00337 1/20 0.66
▸ MAP3K7 O43318 1/20 0.66
▸ SLC28A2 O43868 1/20 0.66
▸ GAPDH P04406 1/20 0.66
▸ MAPK1 P28482 1/20 0.66
▸ ADORA2B P29275 1/20 0.66
▸ STAT6 P42226 1/20 0.66
▸ PI4KA P42356 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ SMN1; SMN2 Q16637 1/20 0.66
▸ PI4K2B Q8TCG2 1/20 0.66
▸ PI4K2A Q9BTU6 1/20 0.66
▸ SLC28A3 Q9HAS3 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19941881 0.91 AHCY (0.61) ADORA3SLC29A1DOT1LADORA2AADORA1
SCHEMBL19927503 0.87 AHCY (0.69) ADORA3SLC29A1DOT1LADORA2AADORA1
SCHEMBL8861594 0.86 DNPH1 (0.70) ADORA1SMN1; SMN2
SCHEMBL21565169 0.86 AHCY (0.61) ADORA3SLC29A1DOT1LADORA2AADORA1
SCHEMBL19146234 0.83 ADORA1 (0.51) ADORA3SLC29A1DOT1LADORA2AADORA1
SCHEMBL14470609 0.83 ADORA3 (0.63) ADORA3SLC29A1DOT1LADORA2AADORA1
SCHEMBL18402898 0.83 ADORA3 (0.63) ADORA3SLC29A1DOT1LADORA2AADORA1
SCHEMBL8861547 0.83 P2RX3 (0.69) SMN1; SMN2
SCHEMBL6900816 0.82 ATM (0.76) ADORA3SLC29A1DOT1LADORA2AADORA1
SCHEMBL26808295 0.82 ADORA3 (0.67) ADORA3SLC29A1DOT1LADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017123669-A1 CYCLIC DINUCLEOTIDES FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY SUCH AS CANCER GLICK GARY (US) 2017-07-20 — — WO disclosed
Send feedback